{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:21:43Z","timestamp":1790313703007,"version":"4.1.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      This study aimed to investigate the types and risk factors of airway clearance dysfunction (ACD) in children with severe pneumonia based on LASSO regression and multivariate\n                      <jats:italic>Logistic<\/jats:italic>\n                      regression analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study was approved by the Hospital Ethics Committee. A retrospective study was conducted on 147 children with severe pneumonia admitted between January 2024 and October 2024. Demographic and clinical characteristics were collected, and the incidence and types of ACD were analyzed. Patients with ACD were assigned to the ACD group, while those without ACD were assigned to the non-ACD group. LASSO regression and multivariate\n                      <jats:italic>Logistic<\/jats:italic>\n                      regression were used to identify risk factors for ACD in these children, and ROC curves were constructed to evaluate the predictive value of these factors for ACD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 63 cases of ACD were observed among children with severe pneumonia, including ineffective coughing, thick sputum, dyspnea, nasal flaring\/ increased nasal congestion, tachypnea, and oxygen saturation &amp;lt;93%, with an incidence rate of 42.86%. Significant differences were found between the ACD group and non-ACD group in terms of age, mechanical ventilation, nutritional status, comorbid respiratory failure, comorbid heart failure, pulmonary rales, and pulmonary rhonchi (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05). Additionally, the ACD group had lower platelet count (PLT), immunoglobulin A (IgA), and immunoglobulin M (IgM) levels, while C-reactive protein (CRP), procalcitonin (PCT), and interleukin-6 (IL-6) levels were higher compared to the non-ACD group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05). Variable screening was performed using the LASSO regression model, identifying three significant influencing factors. These were incorporated into a\n                      <jats:italic>Logistic<\/jats:italic>\n                      regression model, which revealed that mechanical ventilation, CRP, PCT, IL-6, and IgA were influencing factors for ACD in children with severe pneumonia. Based on these findings, an ROC curve was constructed, demonstrating that the combined prediction of mechanical ventilation, CRP, PCT, IL-6, and IgA for ACD in children with severe pneumonia achieved an AUC of 0.882, significantly higher than the AUC of any single indicator (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Children with severe pneumonia are at risk of developing ACD, which may be influenced by mechanical ventilation, CRP, PCT, IL-6, and IgA levels. These five factors can be used to assess the risk of ACD in children with severe pneumonia. Accordingly, clinical measures should be developed to improve airway clearance ability and promote recovery in these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2025.1638103","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:51:10Z","timestamp":1761720670000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk factors for airway clearance dysfunction in children with severe pneumonia: a retrospective study of LASSO model"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiaoyan","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"B1","first-page":"528","article-title":"[Risk factors for progression to severe pneumonia in children visiting the emergency department with pneumonia]","volume":"35","author":"Cao","year":"2023","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"B2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12890-022-02005-y","article-title":"Clinical significance of respiratory virus coinfection in children with Mycoplasma pneumoniae pneumonia","volume":"22","author":"Choo","year":"2022","journal-title":"BMC Pulm Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S2352-4642(23)00030-5","article-title":"The effect of early childhood respiratory infections and pneumonia on lifelong lung function: a systematic review","volume":"7","author":"Collaro","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e849","DOI":"10.1002\/iid3.849","article-title":"Analysis of cytokine levels, cytological findings, and MP-DNA level in bronchoalveolar lavage fluid of children with Mycoplasma pneumoniae pneumonia","volume":"11","author":"Deng","year":"2023","journal-title":"Immun Inflamm Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e804","DOI":"10.1016\/S2214-109X(24)00032-9","article-title":"Effectiveness of bubble continuous positive airway pressure for treatment of children aged 1\u201359 months with severe pneumonia and hypoxaemia in Ethiopia: a pragmatic cluster-randomised controlled trial","volume":"12","author":"Gebre","year":"2024","journal-title":"Lancet Glob Health"},{"key":"B6","doi-asserted-by":"publisher","first-page":"107480","DOI":"10.1016\/j.rmed.2023.107480","article-title":"Chest imaging classification in Mycoplasma pneumoniae pneumonia is associated with its clinical features and outcomes","volume":"221","author":"Huang","year":"2024","journal-title":"Respir Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1016\/j.asjsur.2022.10.085","article-title":"A clinical investigation of hospitalized children with congenital heart disease with severe pneumonia during 2016\u20132020","volume":"46","author":"Zhao","year":"2023","journal-title":"Asian J Surg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jinf.2022.10.010","article-title":"Performance of host-response biomarkers to risk-stratify children with pneumonia in Bhutan","volume":"85","author":"Jullien","year":"2022","journal-title":"J Infect"},{"key":"B9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jfma.2020.08.018","article-title":"Severe Mycoplasma pneumoniae pneumonia requiring intensive care in children, 2010\u20132019","volume":"120","author":"Lee","year":"2021","journal-title":"J Formos Med Assoc"},{"key":"B10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13052-023-01545-1","article-title":"Changes in coagulation markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for Mycoplasma severity","volume":"49","author":"Li","year":"2023","journal-title":"Ital J Pediatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1002\/jmv.25703","article-title":"Risk factors for the development of bronchiolitis obliterans in children with severe adenovirus pneumonia: a retrospective study with dose-response analysis","volume":"92","author":"Zhong","year":"2020","journal-title":"J Med Virol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13052-024-01771-1","article-title":"Risk factor analysis and prediction model construction for severe adenovirus pneumonia in children","volume":"50","author":"Liang","year":"2024","journal-title":"Ital J Pediatr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s12879-020-05270-6","article-title":"Identify clinical factors related to Mycoplasma pneumoniae pneumonia with hypoxia in children","volume":"20","author":"Ling","year":"2020","journal-title":"BMC Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1002\/ppul.26593","article-title":"Clinical features of severe Mycoplasma pneumoniae pneumonia with pulmonary complications in childhood: a retrospective study","volume":"58","author":"Luo","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1136\/jim-2020-001473","article-title":"Diagnostic accuracy of time to first positivity of blood cultures for predicting severe clinical outcomes in children with pneumonia-related bacteremia","volume":"68","author":"Zhang","year":"2020","journal-title":"J Investig Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"6343818","DOI":"10.1155\/2022\/6343818","article-title":"Mycoplasma pneumoniae infections and primary immune deficiencies","volume":"2022","author":"Poddighe","year":"2022","journal-title":"Int J Clin Pract"},{"key":"B17","doi-asserted-by":"publisher","first-page":"04053","DOI":"10.7189\/jogh.11.04053","article-title":"Hypoxaemia prevalence and its adverse clinical outcomes among children hospitalised with WHO-defined severe pneumonia in Bangladesh","volume":"11","author":"Rahman","year":"2021","journal-title":"J Glob Health"},{"key":"B18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/PEC.0000000000002982","article-title":"Viral detection is associated with severe disease in children with suspected community-acquired pneumonia","volume":"39","author":"Ramgopal","year":"2023","journal-title":"Pediatr Emerg Care"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e27128","DOI":"10.1097\/MD.0000000000027128","article-title":"Pathogen distribution and bacterial resistance in children with severe pneumonia: a single-center retrospective study","volume":"100","author":"Su","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1186\/s12913-022-08003-4","article-title":"Decentralizing oxygen availability and use at primary care level for children under-five with severe pneumonia, at 12 health centers in Ethiopia: a pre-post non-experimental study","volume":"22","author":"Tolla","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41598-023-50657-5","article-title":"Viral and bacterial microorganisms in Vietnamese children with severe and non-severe pneumonia","volume":"14","author":"Tran","year":"2024","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1110903","DOI":"10.3389\/fpubh.2023.1110903","article-title":"Antibiotic resistance of Streptococcus pneumoniae in Vietnamese children with severe pneumonia: a cross-sectional study","volume":"11","author":"Tran-Quang","year":"2023","journal-title":"Front Public Health"},{"key":"B23","doi-asserted-by":"publisher","first-page":"8260","DOI":"10.1038\/s41598-024-58784-3","article-title":"A new dynamic nomogram for predicting the risk of severe Mycoplasma pneumoniae pneumonia in children","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci Rep"},{"key":"B24","first-page":"669","article-title":"[Clinical phenotyping of severe Mycoplasma pneumoniae pneumonia in children]","volume":"62","author":"Wang","year":"2024","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"B25","doi-asserted-by":"publisher","first-page":"05003","DOI":"10.7189\/jogh.13.05003","article-title":"Duke T, group ARIR. What are the risk factors for death among children with pneumonia in low- and middle-income countries? A systematic review","volume":"13","author":"Wilkes","year":"2023","journal-title":"J Glob Health"},{"key":"B26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2217\/bmm-2023-0671","article-title":"Study on red blood cell distribution width in children with severe Mycoplasma pneumoniae pneumonia","volume":"18","author":"Wu","year":"2024","journal-title":"Biomark Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13052-024-01661-6","article-title":"Diagnostic value of cytokines in severe childhood Mycoplasma pneumoniae pneumonia combined with adenovirus infection","volume":"50","author":"Yi","year":"2024","journal-title":"Ital J Pediatr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12866-024-03180-0","article-title":"Molecular epidemiology of Mycoplasma pneumoniae pneumonia in children, Wuhan, 2020\u20132022","volume":"24","author":"Xu","year":"2024","journal-title":"BMC Microbiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1002\/ppul.27285","article-title":"Clinical characteristics of Chinese children with EV-D68-associated pneumonia: a single-center retrospective analysis","volume":"59","author":"Xu","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12879-021-05830-4","article-title":"Clinical characteristics of refractory mycoplasma pneumoniae pneumonia in children treated with glucocorticoid pulse therapy","volume":"21","author":"Zhu","year":"2021","journal-title":"BMC Infect Dis"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1638103\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:51:11Z","timestamp":1761720671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1638103\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":30,"alternative-id":["10.3389\/fped.2025.1638103"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1638103","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"article-number":"1638103"}}